Atsena Therapeutics
Signal active
Organization
Contact Information
Overview
Atsena Therapeutics is a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness.
Atsena has an ongoing Phase I/II clinical trial evaluating a potential therapy for one of the most common causes of blindness in children. Its pipeline of clinical and preclinical assets is powered by adeno-associated virus (AAV) technology tailored to overcome the hurdles presented by inherited retinal disease, and its approach is guided by the specific needs of each patient condition.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Atsena Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $3.2B in funding across 36 round(s). With a team of 11-50 employees, Atsena Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Atsena Therapeutics, raised $24.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$87.6M
Details
2
Atsena Therapeutics has raised a total of $87.6M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 8.2M | ||
| 2020 | Early Stage Venture | 55.0M |
Investors
Atsena Therapeutics is funded by 22 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Benjamin Yerxa | - | FUNDING ROUND - Benjamin Yerxa | 55.0M |
| Retinal Degeneration Fund | - | FUNDING ROUND - Retinal Degeneration Fund | 55.0M |
| Atsena Therapeutics | - | FUNDING ROUND - Atsena Therapeutics | 55.0M |
| Hatteras Venture Partners | - | FUNDING ROUND - Hatteras Venture Partners | 55.0M |
Recent Activity
There is no recent news or activity for this profile.